Brown E Sherwood, Vera Elizabeth, Frol Alan B, Woolston Dixie J, Johnson Brandy
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390-8849, United States.
J Affect Disord. 2007 Apr;99(1-3):279-83. doi: 10.1016/j.jad.2006.09.004. Epub 2006 Oct 9.
In animals, stress and corticosteroids can be associated with both reversible and irreversible changes in the hippocampus. Changes in memory and hippocampal structure, perhaps in part due to cortisol elevations, are reported in some patients with mood disorders. Minimal data are available on the effects of long-term exposure to corticosteroids on the human hippocampus. We previously reported greater depressive symptom severity, poorer memory and smaller hippocampal volumes in patients with asthma or rheumatic diseases receiving long-term prednisone therapy than in controls.
In this report, patients and controls were assessed a mean of 4 years after the first assessment to determine if depressive and manic symptoms and cognition remained stable, improved or worsened. Seven prednisone-treated patients and six controls were identified and agreed to reassessment with psychiatric symptom and neurocognitive measures. Follow-up MRIs for hippocampal volume analysis were available for two prednisone-treated participants.
With the exception of an increase in depressive symptoms in those receiving prednisone, participants and controls did not show significant change in mood or cognition from the initial assessment. One participant discontinued prednisone and showed improvement in psychiatric symptoms and cognition. Hippocampal volumes were available in two prednisone-treated participants and showed inconsistent findings.
A limitation is the small sample size.
Our findings, although preliminary in nature, suggest that long-term prednisone therapy is associated with initial changes in mood, memory and hippocampal volume that appear to stabilize over time.
在动物中,应激和皮质类固醇可与海马体的可逆和不可逆变化相关联。一些患有情绪障碍的患者报告了记忆和海马体结构的变化,这可能部分归因于皮质醇升高。关于长期接触皮质类固醇对人类海马体影响的数据极少。我们之前报道,接受长期泼尼松治疗的哮喘或风湿性疾病患者比对照组有更严重的抑郁症状、更差的记忆力和更小的海马体体积。
在本报告中,对患者和对照组在首次评估后平均4年进行评估,以确定抑郁和躁狂症状及认知是否保持稳定、改善或恶化。确定了7名接受泼尼松治疗的患者和6名对照组,并同意通过精神症状和神经认知测量进行重新评估。两名接受泼尼松治疗的参与者有用于海马体体积分析的随访磁共振成像(MRI)。
除了接受泼尼松治疗的患者抑郁症状有所增加外,参与者和对照组自首次评估以来在情绪或认知方面未显示出显著变化。一名参与者停用了泼尼松,其精神症状和认知有所改善。两名接受泼尼松治疗参与者的海马体体积数据显示结果不一致。
样本量小是一个局限性。
我们的研究结果虽然本质上是初步的,但表明长期泼尼松治疗与情绪、记忆和海马体体积的初始变化有关,这些变化似乎会随着时间推移而稳定。